2seventy bio, Inc. (TSVT)
(Delayed Data from NSDQ)
$4.99 USD
+0.01 (0.20%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $5.00 +0.01 (0.20%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth B Momentum F VGM
Brokerage Reports
0 items in cart
2seventy bio, Inc. [TSVT]
Reports for Purchase
Showing records 1 - 20 ( 73 total )
Company: 2seventy bio, Inc.
Industry: Medical - Biomedical and Genetics
Company: 2seventy bio, Inc.
Industry: Medical - Biomedical and Genetics
Company: 2seventy bio, Inc.
Industry: Medical - Biomedical and Genetics
Company: 2seventy bio, Inc.
Industry: Medical - Biomedical and Genetics
Company: 2seventy bio, Inc.
Industry: Medical - Biomedical and Genetics
Company: 2seventy bio, Inc.
Industry: Medical - Biomedical and Genetics
Company: 2seventy bio, Inc.
Industry: Medical - Biomedical and Genetics
Company: 2seventy bio, Inc.
Industry: Medical - Biomedical and Genetics
Company: 2seventy bio, Inc.
Industry: Medical - Biomedical and Genetics
Abecma Now Battling TCE r/r MM at a QTC Near You!
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: 2seventy bio, Inc.
Industry: Medical - Biomedical and Genetics
Company: 2seventy bio, Inc.
Industry: Medical - Biomedical and Genetics
An 8:3 Nod to Abecma; Better than a Kick in the Head
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: 2seventy bio, Inc.
Industry: Medical - Biomedical and Genetics
Early Deaths Could Decide Abecma?s Fate in KarMMa-3
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: 2seventy bio, Inc.
Industry: Medical - Biomedical and Genetics
Company: 2seventy bio, Inc.
Industry: Medical - Biomedical and Genetics
Company: 2seventy bio, Inc.
Industry: Medical - Biomedical and Genetics
Company: 2seventy bio, Inc.
Industry: Medical - Biomedical and Genetics
TSVT?s Abecma Stuck in Traffic; Looks for Open Roads in 2024.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: 2seventy bio, Inc.
Industry: Medical - Biomedical and Genetics
Company: 2seventy bio, Inc.
Industry: Medical - Biomedical and Genetics
ASH 2023 Day 3 Roundup for Covered Companies
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: 2seventy bio, Inc.
Industry: Medical - Biomedical and Genetics
Abecma Caught Speeding; Downgrading to Neutral
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D